المؤلفون: Kelsey MD; Duke University, Durham, North Carolina, USA (M.D.K., L.K.N.)., Newby LK; Duke University, Durham, North Carolina, USA (M.D.K., L.K.N.).

المصدر: Annals of internal medicine [Ann Intern Med] 2022 Aug; Vol. 175 (8), pp. JC86. Date of Electronic Publication: 2022 Aug 02.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/therapeutic use , Cardiovascular Diseases*/prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Cholesterol, LDL ; Ezetimibe/therapeutic use ; Humans ; PCSK9 Inhibitors ; Proprotein Convertase 9

المؤلفون: Al Abbasi B; University of Miami Miller School of Medicine, Palm Beach Campus, Atlantis, Florida, USA (B.A.A., S.B.)., Borzak S; University of Miami Miller School of Medicine, Palm Beach Campus, Atlantis, Florida, USA (B.A.A., S.B.).

المصدر: Annals of internal medicine [Ann Intern Med] 2022 Feb; Vol. 175 (2), pp. JC14. Date of Electronic Publication: 2022 Feb 01.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/therapeutic use , Cardiovascular Diseases*/prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, Antibodies, Monoclonal, Humanized/therapeutic use ; Humans

المؤلفون: Elgendy IY; Weill Cornell Medicine-Qatar, Doha, Qatar (I.Y.E., M.B.E.)., Elshazly MB; Weill Cornell Medicine-Qatar, Doha, Qatar (I.Y.E., M.B.E.).

المصدر: Annals of internal medicine [Ann Intern Med] 2021 Apr; Vol. 174 (4), pp. JC38. Date of Electronic Publication: 2021 Apr 06.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/adverse effects , Cardiovascular Diseases*/prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, Aged ; Cholesterol, LDL ; Humans ; Treatment Outcome

المؤلفون: Kelsey MD; Duke University and Duke Clinical Research Institute, Durham, North Carolina, USA (M.D.K., L.K.N.)., Newby LK; Duke University and Duke Clinical Research Institute, Durham, North Carolina, USA (M.D.K., L.K.N.).

المصدر: Annals of internal medicine [Ann Intern Med] 2022 Nov; Vol. 175 (11), pp. JC126. Date of Electronic Publication: 2022 Nov 01.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Atherosclerosis*/drug therapy , Ezetimibe*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, Humans ; Anticholesteremic Agents/therapeutic use ; Drug Therapy, Combination/adverse effects ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Equivalence Trials as Topic

المؤلفون: Lee J, Holbrook A

المصدر: Annals of internal medicine [Ann Intern Med] 2019 Jun 18; Vol. 170 (12), pp. JC65.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents* , Cardiovascular Diseases* , Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Aged ; Aged, 80 and over ; Cholesterol, LDL ; Humans

المؤلفون: Hlatky MA; Stanford University School of Medicine, Stanford, California (M.A.H.).

المصدر: Annals of internal medicine [Ann Intern Med] 2019 Feb 19; Vol. 170 (4), pp. 264-265. Date of Electronic Publication: 2019 Jan 01.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents* , Pharmaceutical Preparations*, Antibodies, Monoclonal, Humanized ; Cholesterol ; Cost-Benefit Analysis ; Time

المؤلفون: Kazi DS; Beth Israel Deaconess Medical Center, Boston, Massachusetts (D.S.K.)., Penko J; University of California, San Francisco, San Francisco, California (J.P., P.G.C., D.G., P.C.W., K.B.)., Coxson PG; University of California, San Francisco, San Francisco, California (J.P., P.G.C., D.G., P.C.W., K.B.)., Guzman D; University of California, San Francisco, San Francisco, California (J.P., P.G.C., D.G., P.C.W., K.B.)., Wei PC; University of California, San Francisco, San Francisco, California (J.P., P.G.C., D.G., P.C.W., K.B.)., Bibbins-Domingo K; University of California, San Francisco, San Francisco, California (J.P., P.G.C., D.G., P.C.W., K.B.).

المصدر: Annals of internal medicine [Ann Intern Med] 2019 Feb 19; Vol. 170 (4), pp. 221-229. Date of Electronic Publication: 2019 Jan 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Cost-Benefit Analysis*, Acute Coronary Syndrome/*drug therapy , Antibodies, Monoclonal, Humanized/*economics , Anticholesteremic Agents/*economics , Cardiovascular Diseases/*prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*economics , Hypercholesterolemia/*drug therapy, Adult ; Aged ; Angina, Unstable/prevention & control ; Antibodies, Monoclonal, Humanized/therapeutic use ; Anticholesteremic Agents/therapeutic use ; Brain Ischemia/prevention & control ; Cause of Death ; Computer Simulation ; Coronary Disease/prevention & control ; Decision Support Techniques ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Male ; Middle Aged ; Myocardial Infarction/prevention & control ; Quality-Adjusted Life Years ; Stroke/prevention & control ; Treatment Outcome

المؤلفون: Yeboah J

المصدر: Annals of internal medicine [Ann Intern Med] 2018 Jul 17; Vol. 169 (2), pp. JC6.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med

مواضيع طبية MeSH: Anticholesteremic Agents* , Cardiovascular Diseases* , Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Cholesterol, LDL ; Humans

المؤلفون: Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB Sr, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M

المصدر: Annals of internal medicine [Ann Intern Med] 2015 Jul 07; Vol. 163 (1), pp. 40-51.

نوع المنشور: Journal Article; Meta-Analysis; Review; Systematic Review

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Anticholesteremic Agents/*therapeutic use , Hypercholesterolemia/*drug therapy , Proprotein Convertases/*immunology , Serine Endopeptidases/*immunology, Angina, Unstable/prevention & control ; Antibodies, Monoclonal/adverse effects ; Anticholesteremic Agents/adverse effects ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/prevention & control ; Cause of Death ; Cholesterol/blood ; Creatine Kinase/blood ; Female ; Humans ; Hypercholesterolemia/blood ; Lipoprotein(a)/blood ; Male ; Middle Aged ; Myocardial Infarction/prevention & control ; Proprotein Convertase 9

المؤلفون: Gudzune KA, Monroe AK, Sharma R, Ranasinghe PD, Chelladurai Y, Robinson KA

المصدر: Annals of internal medicine [Ann Intern Med] 2014 Apr 01; Vol. 160 (7), pp. 468-76.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review; Systematic Review

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents/*therapeutic use , Coronary Artery Disease/*prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Hypercholesterolemia/*drug therapy, Anticholesteremic Agents/adverse effects ; Azetidines/adverse effects ; Azetidines/therapeutic use ; Bile Acids and Salts/antagonists & inhibitors ; Cholesterol, LDL/blood ; Drug Therapy, Combination ; Ezetimibe ; Fatty Acids, Omega-3 ; Fibric Acids/therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Medication Adherence ; Niacin/therapeutic use ; Randomized Controlled Trials as Topic ; Risk Factors ; Treatment Outcome